1. Home
  2. TRDA vs BGS Comparison

TRDA vs BGS Comparison

Compare TRDA & BGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TRDA

Entrada Therapeutics Inc.

N/A

Current Price

$6.21

Market Cap

275.3M

Sector

Health Care

ML Signal

N/A

BGS

B&G Foods Inc.

HOLD

Current Price

$3.09

Market Cap

297.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRDA
BGS
Founded
2016
1996
Country
United States
United States
Employees
N/A
86
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
275.3M
297.1M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
TRDA
BGS
Price
$6.21
$3.09
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
★ $21.00
$4.90
AVG Volume (30 Days)
290.0K
★ 2.0M
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
★ 14.34%
EPS Growth
N/A
★ 83.02
EPS
N/A
★ N/A
Revenue
$25,421,000.00
★ $1,828,687,000.00
Revenue This Year
$39.97
N/A
Revenue Next Year
$50.80
$0.52
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.56
$2.87
52 Week High
$16.45
$6.38

Technical Indicators

Market Signals
Indicator
TRDA
BGS
Relative Strength Index (RSI) 36.70 40.57
Support Level $5.71 $2.87
Resistance Level $7.89 $3.75
Average True Range (ATR) 0.39 0.11
MACD -0.09 0.01
Stochastic Oscillator 13.85 45.45

Price Performance

Historical Comparison
TRDA
BGS

About TRDA Entrada Therapeutics Inc.

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

About BGS B&G Foods Inc.

B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.

Share on Social Networks: